SWedish Intensive Care Biobank
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUppsala University
About this trial
The goal of this observational study is to understand the genetic and molecular risk factors for developing critical illness in adult intensive care unit (ICU) patients in Sweden. The main questions it aims to answer are:
Which genetic variants are associated with increased risk of critical illness from conditions such as infections, sepsis, and organ failure?
Can circulating proteins and metabolites mediate the effect of genetic risk factors on the severity of illness?
Participants will:
Provide blood samples at ICU admission and again 3-6 months after discharge Consent to genetic analysis and data linkage with national health registries
Have their ICU treatment and outcomes followed using registry and clinical data
This study aims to build a national infrastructure for rapid sample collection and analysis that can also support research in future pandemics.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults admitted to intensive care in Sweden
Disqualifiers
Non adults
Not admitted to intensive care
Trial population
Any patient admitted to intensive care at a hospital in Sweden
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
25,000 Participants
are grouped into 1 trial groupGroup A: ICU admission
Trial outcomes
Primary outcomes
1
30 day mortality
Death of any cause within 30 days of ICU admission
Time frame
30 days2
ICU admission
ICU admission for any specific cause
Time frame
30 daysLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: